-+ 0.00%
-+ 0.00%
-+ 0.00%

MeiraGTx Q2 FY26 net income swings to USD 160.7 million; revenue jumps to USD 321.4 million

PUBT·08/13/2026 12:07:44
Listen to the news
MeiraGTx Q2 FY26 net income swings to USD 160.7 million; revenue jumps to USD 321.4 million
  • MeiraGTx swung to net income of $160.7 million, or $1.76 per share, in Q2 2026 from a net loss.
  • Revenue climbed to $321.4 million from $3.7 million, driven by $204.6 million license revenue and $104.9 million related-party service revenue.
  • R&D expenses rose 72.54% to $57.8 million, while cash and cash equivalents increased to $143.2 million from $65.9 million at year-end 2025.
  • Completed $25 million reacquisition of bota-vec from J&J, targeting global regulatory filings in 2026 ahead of a potential 2027 launch.
  • FDA granted Breakthrough Therapy Designation for AAV2-hAQP1; pivotal Phase 2 enrollment finished, with 12-month data expected in Q2 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MeiraGTx Holdings plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608130800PRIMZONEFULLFEED9809359) on August 13, 2026, and is solely responsible for the information contained therein.